SCHEMBL4898067

SCHEMBL4898067

CCc1ccc(S(=O)(=O)NCCc2ccc(Oc3ccc(F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
POLB P06746 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
AKR1C3 P42330 3/20 0.50
SGMS1 Q86VZ5 2/20 0.50
TAAR1 Q96RJ0 1/20 0.50
MAPT P10636 3/20 0.48
METAP2 P50579 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
LMNA P02545 2/20 0.45
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906430 0.92 AKR1C3 (0.56) ALDH1A1POLBTDP1AKR1C3SGMS1
SCHEMBL4907097 0.91 ALDH1A1 (0.54) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4906132 0.91 ALDH1A1 (0.58) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4899868 0.90 AKR1C3 (0.48) ALDH1A1POLBTDP1AKR1C3MAPT
SCHEMBL4895722 0.90 AKR1C3 (0.55) ALDH1A1AKR1C3SGMS1MAPTSMN1; SMN2
SCHEMBL4895103 0.89 TP53 (0.49) ALDH1A1AKR1C3MAPTSMN1; SMN2LMNA
SCHEMBL4903155 0.89 AKR1C3 (0.48) ALDH1A1POLBTDP1AKR1C3MAPT
SCHEMBL4904654 0.89 ALDH1A1 (0.52) ALDH1A1POLBTDP1AKR1C3SMN1; SMN2
SCHEMBL4899418 0.88 ALDH1A1 (0.58) ALDH1A1POLBCYP1A2CYP2D6CYP2C19
SCHEMBL4905646 0.88 MAPT (0.51) ALDH1A1AKR1C3MAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885POLB 1488/4885CYP1A2 1923/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885POLB 1807/4885CYP1A2 2009/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885POLB 1807/4885CYP1A2 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.